Literature DB >> 27911395

Preparation of Primary Mixed Glial Cultures from Adult Mouse Spinal Cord Tissue.

Jennifer T Malon1, Ling Cao2.   

Abstract

It has been well-accepted that spinal cord glial responses contribute significantly to the development of neuropathic pain. Tremendous information regarding glial activities at the cellular and molecular levels has been obtained through in vitro cell culture systems. The in vitro systems utilized, mainly include primary glia derived from neonatal brain cortical tissue and immortalized cell lines. However, these systems may not reflect the characteristics of spinal cord glial cells in vivo. In order to further investigate the roles of spinal cord glial cells in the development of peripheral nerve injury-induced neuropathic pain using a culture system that better reflects the in vivo condition, our laboratory has developed a method to establish primary spinal cord mixed glial cultures from adult mice. Briefly, spinal cords are collected from adult mice and processed through papain digestion followed by myelin removal with a density-gradient medium. Single cell suspensions are cultured in complete Dulbecco's modified Eagle media (cDMEM) supplemented with 2-mercaptoethanol (2-ME) at 35.9 oC. These culture conditions were optimized specifically for the growth of mixed glial cells. Under these conditions, cells are ready to be used for experimentation between 12 - 14 d (cells are usually in log phase during this time) after the establishment of the culture (D 0) and can be kept in culture conditions up to D 21. This culture system can be used to investigate the responses of spinal cord glial cells upon stimulation with various substances and agents. Besides neuropathic pain, this system can be used to study glial responses in other diseases that involve pathological changes of spinal cord glial cells.

Entities:  

Mesh:

Year:  2016        PMID: 27911395      PMCID: PMC5153361          DOI: 10.3791/54801

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  14 in total

Review 1.  Role of microglia in central nervous system infections.

Authors:  R Bryan Rock; Genya Gekker; Shuxian Hu; Wen S Sheng; Maxim Cheeran; James R Lokensgard; Phillip K Peterson
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

2.  An immortalized cell line expresses properties of activated microglial cells.

Authors:  V Bocchini; R Mazzolla; R Barluzzi; E Blasi; P Sick; H Kettenmann
Journal:  J Neurosci Res       Date:  1992-04       Impact factor: 4.164

3.  A spontaneously immortalized mouse microglial cell line expressing CD4.

Authors:  F Alliot; M C Marty; D Cambier; B Pessac
Journal:  Brain Res Dev Brain Res       Date:  1996-08-20

4.  Immortalization of murine microglial cells by a v-raf/v-myc carrying retrovirus.

Authors:  E Blasi; R Barluzzi; V Bocchini; R Mazzolla; F Bistoni
Journal:  J Neuroimmunol       Date:  1990-05       Impact factor: 3.478

5.  Astrocytic cell clones derived from established cultures of 8-day postnatal mouse cerebella.

Authors:  F Alliot; B Pessac
Journal:  Brain Res       Date:  1984-07-23       Impact factor: 3.252

Review 6.  Glia and pain: is chronic pain a gliopathy?

Authors:  Ru-Rong Ji; Temugin Berta; Maiken Nedergaard
Journal:  Pain       Date:  2013-06-20       Impact factor: 6.961

Review 7.  The role of microglia in central nervous system immunity and glioma immunology.

Authors:  Isaac Yang; Seunggu J Han; Gurvinder Kaur; Courtney Crane; Andrew T Parsa
Journal:  J Clin Neurosci       Date:  2009-11-18       Impact factor: 1.961

8.  CNS-infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain.

Authors:  Ling Cao; Joyce A DeLeo
Journal:  Eur J Immunol       Date:  2008-02       Impact factor: 5.532

9.  Induction of interleukin-1beta by interleukin-4 in lipopolysaccharide-treated mixed glial cultures: microglial-dependent effects.

Authors:  Ling Cao; Liang Fei; Tina Ting-Lan Chang; Joyce A DeLeo
Journal:  J Neurochem       Date:  2007-04-17       Impact factor: 5.372

10.  Microglial content-dependent inhibitory effects of calcitonin gene-related peptide (CGRP) on murine retroviral infection of glial cells.

Authors:  Jennifer Malon; Eliza Grlickova-Duzevik; James Vaughn; Holly Beaulac; Tyler R Vunk; Ling Cao
Journal:  J Neuroimmunol       Date:  2015-01-27       Impact factor: 3.478

View more
  1 in total

1.  A robust platform for high-throughput screening of therapeutic strategies for acute and chronic spinal cord injury.

Authors:  Vaibhav Patil; Enda O'Connell; Leo R Quinlan; Howard Fearnhead; Siobhan McMahon; Abhay Pandit
Journal:  iScience       Date:  2021-02-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.